Home
HelpTest ID BLOD0097 Alpha-Subunit Pituitary Tumor Marker, Serum
Useful For
Adjunct in the diagnosis of pituitary tumors
As part of the follow-up of treated pituitary tumor patients
Differential diagnosis of thyrotropin-secreting pituitary tumor versus thyroid hormone resistance
Differential diagnosis of constitutional delay of puberty versus hypogonadotrophic hypogonadism
Specimen Type
SerumOrdering Guidance
This test should not be ordered on pregnant patients.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial
Specimen Minimum Volume
0.35 mL
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | OK |
| Gross icterus | OK |
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum | Frozen (preferred) | 90 days | |
| Refrigerated | 7 days |
Day(s) Performed
Sunday
Report Available
2 to 8 daysMethod Name
Immunochemiluminescent Assay
Performing Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
82397
Forms
If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.
Secondary ID
9003Reporting Name
AlphaSubunit Pituitary Tumor MarkerReference Values
PEDIATRIC
≤5 days: ≤50 ng/mL
6 days-12 weeks: ≤10 ng/mL
3 months-17 years: ≤1.2 ng/mL
Tanner II-IV*: ≤1.2 ng/mL
ADULTS
Males: ≤0.5 ng/mL
Premenopausal females: ≤1.2 ng/mL
Postmenopausal females: ≤1.8 ng/mL
Pediatric and adult reference values based on Mayo studies.
*Puberty onset (transition from Tanner stage I to Tanner stage II) occurs for boys at a median age of 11.5 (±2) years and for girls at a median age of 10.5 (±2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African American girls. For boys, there is no proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage V (adult) should be reached by age 18.
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.SANFORD INTERFACE BUILD INFORMATION
| Result Code | Result Code Description |
|---|---|
| 13037 | Alpha Subunit Pituitary Tumor Marker |